Login
You're viewing the functional.cafe public feed.
  • Sep 15, 2026, 2:17 AM

    Nanobodies are inspired by the antibodies of llamas and their kin. Instead of a giant, y-shaped protein, a nanobody is essentially a piece of one of the y’s tips. Because they’re smaller and lack the species-specific trunk of traditional antibodies, nanobodies are easier to produce in bulk and less likely to cause adverse reactions. Last year, researchers demonstrated that a cocktail of these bitty antibodies could offer protection against a diverse array of snakes . But for the new study, the team zeroed in on one group in particular: cobras in India, a country that bears the greatest burden of snakebite death in the world and where the current antivenom all too often falls short. (2/3)

    💬 1🔄 0⭐ 0

Replies

  • Sep 15, 2026, 2:17 AM

    Small doses of a mixture of just five nanobodies saved mice from lethal doses of venom from India’s deadliest cobra species, even when administered to the animals half an hour after the toxins. “ Mice that were paralyzed or had typical neurotoxic symptoms would revert to a completely asymptomatic state ,” explained coauthor Kartik Sunagar in a statement.

    The next step, of course, is to test these nanobodies in people—first for safety in clinically relevant doses, and then for how well they work. So, they aren’t going to be given to snakebite patients this year. But what’s especially exciting about the work is that it demonstrates that “very small amounts of carefully selected and engineered antibodies” can work, according to Sunagar, and the approach could be applied regionally to quickly develop much more effective antivenoms for the hardest hit parts of the world. (3/3)

    💬 0🔄 1⭐ 0